| Name | Title | Contact Details |
|---|
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
Neurosurgery and Spine Consultants of East Tennessee is a Knoxville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Johnson Memorial Hospital (IN) is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Johnson Memorial Hospital (IN) is based in Franklin, IN. You can find more information on Johnson Memorial Hospital (IN) at www.johnsonmemorial.org
Biopro Implants is a Port Huron, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Considine and Associates is a Laguna Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.